Serra A, Bolasco P, Satta L, Nicolosi A, Uccheddu A, Piga M
Medicina Nucleare, Policlinico Universitario, Università degli Studi, Cagliari, Italy.
Radiol Med. 2006 Oct;111(7):999-1008. doi: 10.1007/s11547-006-0098-0. Epub 2006 Oct 11.
Our purpose was to assess the clinical value and additional benefit of fusion single-photon computed tomography (SPECT) and computed tomography (CT) images in locating the parathyroids in a selected group of patients affected by primary (PHP) and secondary hyperparathyroidism (SHP).
Sixteen patients (11 women and five men; age range 35-80 years) with severe hyperparathyroidism (HP) (ten PHP, six SHP) were studied by ultrasound (US), and, after i.v. injection of 370 MBq of 99mTc-sestamibi, by planar parathyroid scintigraphy, SPECT and SPECT/CT using a dual-detector scintillation camera GE Infinia Hawkeye. All patients underwent parathyroidectomy.
US findings were inconclusive in 12/16 patients affected by multinodular goitre, and two probable eutopic parathyroid glands were identified. "Double phase" parathyroid scintigraphy identified 14 probable parathyroid glands, SPECT 23 (14 ectopic and nine eutopic) and SPECT/CT confirmed all 23 probable parathyroid lesions, offering more precise localisation and an evident improvement in diagnostic accuracy. Sixteen of these foci of increased uptake were hyperplastic parathyroid glands, six were adenomas, one was a parathyroid carcinoma and one was a thyroid follicular carcinoma. Surgical detection of the 23 sestamibi-positive lesions was correctly matched with 100% of SPECT/CT images and 61% of SPECT data alone. Hybrid imaging thus provided additional data in 39% of lesions, and in three patients with retrotracheal glands, it modified the surgical approach.
We believe 99mTc-sestamibi SPECT/CT to be a more reliable presurgical method to study a patient subgroup affected by PHP or SHP in whom conventional US and other scintigraphic methods have failed for intrinsic reasons due to the concomitant presence of multinodular goitre or ectopic parathyroid gland. The additional practical benefit derived from this methodology was evident. In fact, anatomical information provided by CT enables precise localisation of the functional abnormalities highlighted by SPECT, and both are essential to a correct surgical approach.
我们的目的是评估融合单光子计算机断层扫描(SPECT)和计算机断层扫描(CT)图像在一组原发性甲状旁腺功能亢进症(PHP)和继发性甲状旁腺功能亢进症(SHP)患者中定位甲状旁腺的临床价值和额外益处。
对16例患有严重甲状旁腺功能亢进症(HP)(10例PHP,6例SHP)的患者(11名女性和5名男性;年龄范围35 - 80岁)进行了超声(US)检查,静脉注射370 MBq的99mTc - 甲氧基异丁基异腈后,使用双探测器闪烁相机GE Infinia Hawkeye进行平面甲状旁腺闪烁显像、SPECT和SPECT/CT检查。所有患者均接受了甲状旁腺切除术。
在16例患有结节性甲状腺肿的患者中,12例的超声检查结果不明确,发现了2个可能的正常位置甲状旁腺。“双期”甲状旁腺闪烁显像发现了14个可能的甲状旁腺,SPECT发现了23个(14个异位和9个正常位置),SPECT/CT证实了所有23个可能的甲状旁腺病变,提供了更精确的定位并显著提高了诊断准确性。这些摄取增加的病灶中,16个是增生的甲状旁腺,6个是腺瘤,1个是甲状旁腺癌,1个是甲状腺滤泡癌。手术中对23个甲氧基异丁基异腈阳性病变的检测与100%的SPECT/CT图像以及仅61%的SPECT数据正确匹配。因此,融合成像在39%的病变中提供了额外的数据,并且在3例气管后腺体患者中,它改变了手术方法。
我们认为99mTc - 甲氧基异丁基异腈SPECT/CT是一种更可靠的术前检查方法,可用于研究因结节性甲状腺肿或异位甲状旁腺的同时存在而导致传统超声和其他闪烁显像方法因内在原因失败的PHP或SHP患者亚组。这种方法带来的额外实际益处是显而易见的。事实上,CT提供的解剖信息能够精确地定位SPECT突出显示的功能异常,而这两者对于正确的手术方法都是必不可少的。